These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 16193855

  • 1. [Concomitant use of statins and cytochrome P 450 inhibitors in Croatia].
    Reiner Z, Galić M, Hanzevacki M, Tedeschi-Reiner E.
    Lijec Vjesn; 2005; 127(3-4):65-8. PubMed ID: 16193855
    [Abstract] [Full Text] [Related]

  • 2. Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization.
    Shanahan RL, Kerzee JA, Sandhoff BG, Carroll NM, Merenich JA.
    Pharmacotherapy; 2005 Mar; 25(3):345-51. PubMed ID: 15843281
    [Abstract] [Full Text] [Related]

  • 3. Statin safety and drug interactions: clinical implications.
    Bottorff MB.
    Am J Cardiol; 2006 Apr 17; 97(8A):27C-31C. PubMed ID: 16581325
    [Abstract] [Full Text] [Related]

  • 4. The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.
    García-Rodríguez LA, González-Pérez A, Stang MR, Wallander MA, Johansson S.
    Pharmacoepidemiol Drug Saf; 2008 Oct 17; 17(10):953-61. PubMed ID: 18425987
    [Abstract] [Full Text] [Related]

  • 5. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z, Mihatov S, Milicić D, Bergovec M, Planinc D, TASPIC-CRO Study Group Investigators.
    Eur J Cardiovasc Prev Rehabil; 2006 Aug 17; 13(4):646-54. PubMed ID: 16874158
    [Abstract] [Full Text] [Related]

  • 6. Does simvastatin cause more myotoxicity compared with other statins?
    Backes JM, Howard PA, Ruisinger JF, Moriarty PM.
    Ann Pharmacother; 2009 Dec 17; 43(12):2012-20. PubMed ID: 19920157
    [Abstract] [Full Text] [Related]

  • 7. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A.
    Clin Ther; 2005 Nov 17; 27(11):1806-14. PubMed ID: 16368451
    [Abstract] [Full Text] [Related]

  • 8. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
    Fraunfelder FW, Richards AB.
    Ophthalmology; 2008 Dec 17; 115(12):2282-5. PubMed ID: 18930555
    [Abstract] [Full Text] [Related]

  • 9. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
    Iskedjian M, Walker JH, Desjardins O, Robin AL, Covert DW, Bergamini MV, Einarson TR.
    Curr Med Res Opin; 2009 Aug 17; 25(8):1879-88. PubMed ID: 19530975
    [Abstract] [Full Text] [Related]

  • 10. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B, Derntl M, Marx M, Lercher P, Gössinger HD.
    Am Heart J; 2007 Jan 17; 153(1):113-9. PubMed ID: 17174648
    [Abstract] [Full Text] [Related]

  • 11. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W, Wilkins A, Pociupany R, Ponikowski P.
    Kardiol Pol; 2008 Jun 17; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [Abstract] [Full Text] [Related]

  • 12. Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans.
    Marelli C, Gunnarsson C, Ross S, Haas S, Stroup DF, Cload P, Clopton P, DeMaria AN.
    J Am Coll Cardiol; 2011 Jul 26; 58(5):530-7. PubMed ID: 21777752
    [Abstract] [Full Text] [Related]

  • 13. Risk and predictability of drug interactions in the elderly.
    Levy RH, Collins C.
    Int Rev Neurobiol; 2007 Jul 26; 81():235-51. PubMed ID: 17433928
    [Abstract] [Full Text] [Related]

  • 14. Outcomes in 45 patients with statin-associated myopathy.
    Hansen KE, Hildebrand JP, Ferguson EE, Stein JH.
    Arch Intern Med; 2007 Jul 26; 165(22):2671-6. PubMed ID: 16344427
    [Abstract] [Full Text] [Related]

  • 15. Statin prescription by Croatian family doctors lack of systematic proactive approach to cardiovascular disease prevention.
    Vrdoljak D, Bergman Marković B, Kranjcević K.
    Coll Antropol; 2009 Dec 26; 33(4):1369-74. PubMed ID: 20102095
    [Abstract] [Full Text] [Related]

  • 16. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
    Bradford WD, Kleit AN, Nietert PJ, Ornstein S.
    Clin Ther; 2006 Dec 26; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
    [Abstract] [Full Text] [Related]

  • 17. Impact of concurrent medication use on statin adherence and refill persistence.
    Grant RW, O'Leary KM, Weilburg JB, Singer DE, Meigs JB.
    Arch Intern Med; 2004 Nov 22; 164(21):2343-8. PubMed ID: 15557413
    [Abstract] [Full Text] [Related]

  • 18. [FARIM - FARmakoterapie po Infarktu Myokardu (Post-Myocardial Infarction Pharmacotherapy Study)].
    Spinar J, Vítovec J, Spinarová L, Zastoupení resitelů studie FARIM.
    Vnitr Lek; 2011 Sep 22; 57(9):778-84. PubMed ID: 21957774
    [Abstract] [Full Text] [Related]

  • 19. Effects of cerivastatin withdrawal on statin persistence.
    Reaume KT, Erickson SR, Dorsch MP, Dunham NL, Hiniker SM, Prabhakar N, Kline-Rogers EM, Eagle KA.
    Ann Pharmacother; 2008 Jul 22; 42(7):956-61. PubMed ID: 18523235
    [Abstract] [Full Text] [Related]

  • 20. Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.
    Goettsch WG, Heintjes EM, Kastelein JJ, Rabelink TJ, Johansson S, Herings RM.
    Pharmacoepidemiol Drug Saf; 2006 Jul 22; 15(7):435-43. PubMed ID: 16761304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.